Back to search
Tophaceous Gout
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Tophaceous Gout trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Tophaceous Gout trials you may qualify forThe primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult par…
This study will assess the effect of AR882 and XOI co-administration on sUA lowering as well as reducing tophus burden in the population that has failed uricase…
This safety and feasibility, open-label study of up to 9 subjects will examine a group of subjects with poorly controlled tophaceous gout (intolerant to or inef…
The main objective is to evaluate the decrease in crystalline volume of the target tophus using Dual-Energy Computed Tomography (DECT), after 6 months +/- 1 mon…
This study will assess the serum urate lowering effect, tophi reduction, and safety of AR882 alone and in combination with allopurinol in patients with tophaceo…